Comerica Bank Has $1.78 Million Stock Position in Globe Life Inc. $GL

Key Points

• Comerica Bank sharply cut its stake in Globe Life by 91.7% in Q4, selling 139,930 shares and leaving a $1.78 million position of 12,732 shares.
• Company insiders have been net sellers recently — including the CEO and an EVP — with 121,470 shares sold last quarter (about $18.0 million), leaving insiders owning 2.11% of the stock.
• Analysts remain broadly positive with an average "Buy" rating and a target of $172.67; Globe Life issued FY2026 EPS guidance of 15.40–15.90 and declared a quarterly dividend of $0.33 (annual yield ~0.9%).

Comerica Bank reduced its stake in shares of Globe Life Inc. (NYSE:GL - Free Report) by 91.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,732 shares of the company's stock after selling 139,930 shares during the quarter. Comerica Bank's holdings in Globe Life were worth $1,781,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Globe Life by 6.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company's stock valued at $1,237,000 after buying an additional 607 shares during the period. NewEdge Advisors LLC increased its stake in Globe Life by 368.1% during the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company's stock valued at $897,000 after acquiring an additional 5,352 shares during the period. Goldman Sachs Group Inc. increased its stake in Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company's stock valued at $74,161,000 after acquiring an additional 58,163 shares during the period. Empowered Funds LLC acquired a new position in Globe Life in the 1st quarter valued at approximately $428,000. Finally, Focus Partners Wealth raised its holdings in Globe Life by 8.3% in the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company's stock valued at $1,127,000 after acquiring an additional 656 shares in the last quarter. 81.61% of the stock is owned by institutional investors.

Insider Activity at Globe Life

In related news, EVP Robert Edward Hensley sold 712 shares of the stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $142.59, for a total transaction of $101,524.08. Following the sale, the executive vice president directly owned 8,580 shares in the company, valued at $1,223,422.20. This represents a 7.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Frank M. Svoboda sold 12,500 shares of Globe Life stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the transaction, the chief executive officer owned 35,868 shares of the company's stock, valued at approximately $5,192,969.04. The trade was a 25.84% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 121,470 shares of company stock valued at $17,988,368. Insiders own 2.11% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on GL. Evercore set a $157.00 price objective on Globe Life in a report on Wednesday, February 18th. Weiss Ratings lowered Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research note on Monday, April 27th. JPMorgan Chase & Co. raised their target price on Globe Life from $180.00 to $181.00 and gave the stock an "overweight" rating in a research report on Thursday, February 5th. Piper Sandler upgraded shares of Globe Life to a "strong-buy" rating in a research note on Thursday, April 2nd. Finally, Wells Fargo & Company boosted their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an "overweight" rating in a report on Friday, April 10th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $172.67.

Globe Life Price Performance

Shares of GL stock opened at $154.49 on Thursday. The stock's fifty day simple moving average is $144.75 and its 200 day simple moving average is $140.27. Globe Life Inc. has a one year low of $116.73 and a one year high of $156.69. The firm has a market cap of $12.12 billion, a price-to-earnings ratio of 10.68 and a beta of 0.50. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 21.30% and a net margin of 19.38%.The company had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the prior year, the company earned $3.07 earnings per share. The business's revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, analysts expect that Globe Life Inc. will post 15.53 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be given a $0.33 dividend. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. Globe Life's payout ratio is 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.